About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Clinical Updates In Advanced Bladder Cancer
Clinical Updates In Advanced Bladder Cancer
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
ASCO 2022 Panel Discussion on Current Strategies and Trials on Bladder Preservation
By
ecancer
FEATURING
Petros Grivas
,
Robert Jones
,
Phil Cornford
,
Kurt Miller
By
ecancer
FEATURING
Petros Grivas
,
Robert Jones
,
Phil Cornford
,
Kurt Miller
127 views
June 23, 2022
0 Comments
Login to view comments.
Click here to Login
Clinical Updates In Advanced Bladder Cancer
09:36
ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on EV-103 Cohort H: Antitumor Activity of Neoadjuvant T…
Feat.
N. Mar
05:47
ESMO 2022 Conference Coverage
ESMO 2022 on the Impact of TURBT and Intravesical BCG vs. Radical Cy…
Feat.
P. Haddad
04:35
ESMO 2022 Conference Coverage
ESMO 2022 on the 4-Factor Model to Predict Response and Survival Ben…
Feat.
G. Sonpavde
05:38
Total Health
2022 ASCO Updates in Bladder and Prostate Cancers
Feat.
M. Bupathi
13:49
ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on Multi-Institutional Matched Comparison of Radical Cy…
Feat.
A. Zlotta
08:54
ASCO Genitourinary Cancers Symposium
Trials in Progress in Neoadjuvant Systemic Therapy in MIBC
Feat.
P. Grivas
11:11
ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoad…
Feat.
D. Petrylak
13:17
ASCO Genitourinary Cancers Symposium
ASCO GU 2022 Highlights on the ADCs in Advanced Urothelial Cancer: C…
Feat.
S. Tagawa
18:11
PROSCA & BLADDR 2021
Perioperative Systemic Therapies in MIBC
Feat.
F. Witjes
14:37
PROSCA & BLADDR 2021
Are We Ready for ctDNA Triggered Therapy for Bladder Cancer?
Feat.
B. Szabados
06:49
CancerGRACE
PD-L1 in Metastatic Bladder Cancer
Feat.
J. Brown
08:05
ASCO 2022 Conference Coverage
ASCO 2022: A Phase II Study of Gem + Cis Chemo in MIBC With Bladder …
Feat.
G. Iyer
09:17
ASCO 2022 Conference Coverage
ASCO 2022 Real-World Treatment Patterns and Clinical Outcomes With 1…
Feat.
G. Sonpavde
20:21
ASCO 2022 Conference Coverage
ASCO 2022 Highlights From Educational Sessions and Updates in Bladde…
Feat.
P. Grivas
03:11
ASCO 2022 Conference Coverage
ASCO 2022 Defining "Platinum-Ineligible" Pts With Metastat…
Feat.
S. Gupta
03:44
ASCO 2022 Conference Coverage
ASCO 2022 MAIN-CAV: Phase III Randomized Trial of Maintenance Caboza…
Feat.
S. Gupta
21:40
ecancer
ASCO 2022 Panel Discussion on Current Strategies and Trials on Bladd…
Feat.
P. Grivas,
R. Jones,
P. Cornford,
K. Miller
21:32
ASCO 2022 Conference Coverage
ASCO 2022 Bladder Cancer Highlights
Feat.
G. Sonpavde
05:32
Penn Medicine Abramson Cancer Center
Penn Medicine Updates on RCC & Bladder Cancer Treatment
Feat.
V. Narayan
12:10
ESMO 2022 Conference Coverage
ESMO 2022: Key Bladder Cancer/Urothelial Carcinoma Presentations
Feat.
G. Sonpavde
05:10
ESMO 2022 Conference Coverage
ESMO 2022 on the Results From the PREVAIL Prospective Cohort Study: …
Feat.
P. Grivas
38:03
PROSCA & BLADDR 2022
Multiple Cases Discussion: Oligometastatic Bladder Cancer
Feat.
V. Fonteyne,
K. Gust,
U. Vogl,
P. Grivas
07:13
PROSCA & BLADDR 2022
DEBATE: Are We Evolving Towards a Platinum-Free Future in Bladder Ca…
Feat.
A. Bamias
16:02
PROSCA & BLADDR 2022
The Growing Landscape of Antibody-Drug Conjugates in Advanced UC
Feat.
P. Grivas
